Cannabis Use
Find information on Cannabis Use Disorder diagnosis, including clinical documentation, ICD-10-CM coding (C and F codes), DSM-5 criteria, Marijuana Use assessment, and THC Use treatment options. Learn about healthcare best practices for cannabis-related diagnoses and improve your medical coding accuracy. This resource provides valuable insights for clinicians, healthcare professionals, and medical coders dealing with substance use disorders.
Problematic cannabis (marijuana, THC) consumption impacting health or daily life.
Impaired memory, red eyes, increased appetite, anxiety, paranoia, withdrawal symptoms.
Primary care, addiction treatment centers, mental health clinics, detox facilities.
ICD-10 Code Families
Complete code families applicable to F12.90
When to use each related code
| Description | When to use |
|---|---|
| Cannabis use disorder. | Problematic cannabis use leading to clinically significant impairment or distress. |
| Cannabis intoxication. | Reversible cannabis-induced symptoms like euphoria, anxiety, and impaired judgment during or shortly after use. |
| Cannabis withdrawal. | Symptoms like irritability, anxiety, sleep disturbance following cessation of heavy, prolonged cannabis use. |
Best-practice checklist
- ✓Cannabis use frequency, amount, and method
- ✓Onset and duration of cannabis use
- ✓Symptoms related to cannabis use
- ✓Impact of use on daily life (social, occupational)
- ✓Relevant ICD-10 codes (e.g., F12.10, F12.20)
Common pitfalls to avoid
Coding cannabis use without specifying type (abuse, dependence, etc.) leads to inaccurate severity and reimbursement.
Failing to capture co-occurring mental health or physical conditions associated with cannabis use impacts quality reporting.
Insufficient documentation of cannabis use frequency, duration, and impact on function hinders accurate coding and audit defense.
Best-practice tips
- 01Screen for cannabis use via standardized questionnaires.
- 02Document frequency, amount, and method of cannabis use.
- 03Assess for cannabis-related health impacts (physical, mental).
- 04Consider ICD-10 codes for cannabis use disorders (F12.-).
- 05Educate patients on risks/benefits and cessation resources.
Step-by-step checklist
- 1
Screen for frequency, quantity, and method of cannabis use.
- 2
Document cannabis use impacts on physical and mental health.
- 3
Assess for Cannabis Use Disorder per DSM-5 criteria.
- 4
Consider drug interactions and contraindications.
- 5
Educate patient on risks/benefits and harm reduction strategies.
Ready-to-paste narrative
Patient presents with symptoms consistent with cannabis use disorder, also known as marijuana use disorder or THC use disorder. The patient reports regular cannabis use, exhibiting signs of increased tolerance, withdrawal symptoms upon cessation, and continued use despite negative consequences. Assessment includes a detailed substance use history, including frequency, quantity, method of ingestion (e.g., smoking, vaping, edibles), and duration of use. The patient's reported symptoms include craving, irritability, anxiety, sleep disturbances, decreased appetite, and difficulty concentrating. Physical examination may reveal conjunctival injection, increased heart rate, and dry mouth. Differential diagnoses considered include other substance use disorders, anxiety disorders, and mood disorders. The patient's cannabis use meets the DSM-5 criteria for cannabis use disorder, moderate severity. Treatment plan includes motivational interviewing, cognitive behavioral therapy (CBT) for substance abuse, and referral to support groups for cannabis cessation. Patient education on the risks associated with continued cannabis use, including potential respiratory issues, cardiovascular complications, and mental health implications, was provided. Follow-up appointment scheduled to monitor progress and adjust treatment as needed. ICD-10 code F12.20 will be used for billing and coding purposes. Continued monitoring and support are crucial for successful cannabis cessation and relapse prevention.
Common questions and answers
What are the most effective evidence-based screening tools for cannabis use disorder (CUD) in adolescents during a routine clinical visit?+
Several validated screening tools can effectively identify cannabis use disorder (CUD) in adolescents. The CRAFFT (Car, Relax, Alone, Forget, Friends, Trouble) is a brief, validated screening tool specifically designed for adolescents. It assesses six domains related to substance use. The ASSIST (Alcohol, Smoking and Substance Involvement Screening Test) is another option that screens for a broader range of substance use, including cannabis. Additionally, incorporating the DSM-5 criteria for CUD into a clinical interview can provide a comprehensive assessment. This involves inquiring about frequency of use, cravings, impairment in functioning, and withdrawal symptoms. Explore how integrating these screening tools into your workflow can enhance early identification and intervention for CUD. Consider implementing routine screening as part of standard adolescent healthcare.
How do I differentiate between cannabis-induced psychosis and a primary psychotic disorder in a young adult presenting with new-onset psychotic symptoms?+
Differentiating between cannabis-induced psychosis and a primary psychotic disorder like schizophrenia can be challenging in young adults. A thorough clinical history is crucial, focusing on the timeline of symptom onset concerning cannabis use. If psychotic symptoms predate cannabis use or persist significantly beyond periods of abstinence (typically weeks to months), a primary psychotic disorder is more likely. Assess for a family history of psychotic illness, which increases the risk of primary psychosis. Cognitive testing can also be helpful, as cognitive deficits are often more pronounced in primary psychotic disorders. Furthermore, consider monitoring symptom resolution during a period of monitored abstinence. Learn more about the diagnostic criteria for both cannabis-induced psychosis and primary psychotic disorders to aid in accurate diagnosis and appropriate treatment planning.
What are the best strategies for motivating a patient with cannabis use disorder to engage in treatment, considering the impact of motivational interviewing techniques and stages of change?+
Motivational interviewing (MI) is a highly effective strategy for engaging patients with cannabis use disorder (CUD) in treatment. MI principles, such as expressing empathy, developing discrepancy, rolling with resistance, and supporting self-efficacy, can help facilitate behavior change. Tailor your approach based on the patient's stage of change within the transtheoretical model (precontemplation, contemplation, preparation, action, maintenance). For patients in precontemplation, focus on raising awareness about the potential negative consequences of their cannabis use. For those in contemplation, explore ambivalence and help them weigh the pros and cons of change. In the preparation stage, assist with developing a plan for reducing or quitting cannabis use. Consider implementing motivational enhancement therapy (MET), which incorporates MI principles, to improve treatment engagement and outcomes. Learn more about how MI and the stages of change model can inform your approach to patient care in CUD.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.